患有心房的患者的寿命更长,更好:第九届AFNET/EHRA共识会议
Dominik Linz1,2, Jason G Andrade3,4, Elena Arbelo5,6,7,8
1Department of Cardiology, Maastricht University Medical Center, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.
概括
建议对心房动 (AF) 患者进行主动节律管理. 在AF中较低的心律失常负担降低了中风风险,但在这些情况下需要更多的研究来准确预测.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 数字健康数字健康
背景情况:
- 最近的试验强调了在心房动 (AF) 中积极节律管理的好处.
- 低心律失常负担与减少AF相关并发症相关.
- 第九届AFNET/EHRA共识会议召开专家会议,讨论AF管理问题.
研究的目的:
- 总结第九届AFNET/EHRA共识会议的主要成果.
- 为AF患者提供有关主动节律管理和中风风险的指导.
- 突出综合护理和新兴技术在AF治疗中的作用.
主要方法:
- 达成共识的会议涉及83名国际专家.
- 讨论和综合最近的试验数据和临床发现.
- 专注于设备检测到的AF,中风风险预测和并发症.
主要成果:
- 积极的节律管理应该是适合AF患者的默认治疗.
- 设备检测到的低负荷的AF表明中风风险低;抗凝血的好处和风险需要仔细考虑.
- 加强中风风险预测需要进一步研究,使用生物标志物,遗传学和成像.
- 诊断AF需要系统评估和治疗同时存在的心血管疾病.
- 机器学习显示出AF检测和预测的前景,需要临床数据科学合作.
结论:
- 患有较低AF负担的患者面临中风和心血管事件的风险降低.
- 综合管理将节律控制,抗凝血,节律控制和并发症治疗结合起来,改善了患者的治疗结果.
- 进一步的研究和技术整合对于优化AF护理至关重要.
关键词:
AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFNET AFnet is also known as AFnet is also known as这是一种抗凝血药物.人工智能的人工智能是人工智能.在心房心肌病症.心房动是一种心房动.生物标志物 生物标志物流血 出血 流血 出血导管切除 导管切除 导管切除 导管切除认知功能 认知功能达成共识声明 达成共识声明费用 费用 费用 费用 费用 费用 费用痴呆症是一种痴呆症.在EHRA的研究中,EHRA准则 准则 准则 准则心脏衰竭是因为心脏衰竭.综合护理是一项综合护理.结果的结果.护理的质量护理的质量研究研究研究研究研究研究.研究重点研究重点.节奏管理是节奏管理.查检查 查检查 查检查一次性中风,中风.技术 技术 技术 技术 技术相关概念视频
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


